1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2017-2028)
2.2 Adoptive Cell Transfer Therapy Growth Trends by Region
2.2.1 Adoptive Cell Transfer Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adoptive Cell Transfer Therapy Historic Market Size by Region (2017-2022)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2023-2028)
2.3 Adoptive Cell Transfer Therapy Market Dynamics
2.3.1 Adoptive Cell Transfer Therapy Industry Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2017-2022)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2021
3.5 Adoptive Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2017-2022)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2023-2028) 5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2017-2028)
6.2 North America Adoptive Cell Transfer Therapy Market Size by Type
6.2.1 North America Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
6.2.2 North America Adoptive Cell Transfer Therapy Market Size by Type (2023-2028)
6.2.3 North America Adoptive Cell Transfer Therapy Market Share by Type (2017-2028)
6.3 North America Adoptive Cell Transfer Therapy Market Size by Application
6.3.1 North America Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
6.3.2 North America Adoptive Cell Transfer Therapy Market Size by Application (2023-2028)
6.3.3 North America Adoptive Cell Transfer Therapy Market Share by Application (2017-2028)
6.4 North America Adoptive Cell Transfer Therapy Market Size by Country
6.4.1 North America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
6.4.2 North America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2017-2028)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
7.2.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2023-2028)
7.2.3 Europe Adoptive Cell Transfer Therapy Market Share by Type (2017-2028)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
7.3.2 Europe Adoptive Cell Transfer Therapy Market Size by Application (2023-2028)
7.3.3 Europe Adoptive Cell Transfer Therapy Market Share by Application (2017-2028)
7.4 Europe Adoptive Cell Transfer Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
7.4.2 Europe Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2017-2028)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2017-2028)
9.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type
9.2.1 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Adoptive Cell Transfer Therapy Market Share by Type (2017-2028)
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Application
9.3.1 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Adoptive Cell Transfer Therapy Market Share by Application (2017-2028)
9.4 Latin America Adoptive Cell Transfer Therapy Market Size by Country
9.4.1 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2017-2028)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.2.5 Kite Pharma Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.4.5 Juno Therapeutics Recent Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.5.5 Celgene Corporation Recent Developments
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Details
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.6.5 CARsgen Therapeutics Recent Developments
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Details
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.7.5 Sorrento Therapeutics Recent Developments
11.8 Legend Biotech
11.8.1 Legend Biotech Company Details
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.8.5 Legend Biotech Recent Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.9.5 Atara Biotherapeutics Recent Developments
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Details
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.10.5 Aurora Biopharma Recent Developments
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Details
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.11.5 Autolus Therapeutics PLC Recent Developments
11.12 Bluebird
11.12.1 Bluebird Company Details
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.12.5 Bluebird Recent Developments
11.13 Carina Biotech
11.13.1 Carina Biotech Company Details
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.13.5 Carina Biotech Recent Developments
11.14 Athenex
11.14.1 Athenex Company Details
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.14.5 Athenex Recent Developments
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Details
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.16.5 Hengrui Yuanzheng Recent Developments
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Details
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.17.5 Eureka Therapeutics Recent Developments
11.18 WuXi Juno
11.18.1 WuXi Juno Company Details
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.18.5 WuXi Juno Recent Developments
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Details
11.19.2 Shenzhen Inno Immunity Business Overview
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.19.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.19.5 Shenzhen Inno Immunity Recent Developments
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Details
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.20.5 Shenzhen Binde Bio Recent Developments
11.21 Kerui Bio
11.21.1 Kerui Bio Company Details
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.21.5 Kerui Bio Recent Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Details
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.22.5 Adaptimmune Recent Developments
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Details
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.23.5 Altor Bioscience Corporation Recent Developments
11.24 Cellectis
11.24.1 Cellectis Company Details
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.24.5 Cellectis Recent Developments
11.25 Takara Bio
11.25.1 Takara Bio Company Details
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.25.5 Takara Bio Recent Developments
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Details
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.26.5 Unum Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
